1. Home
  2. NBN vs SPTX Comparison

NBN vs SPTX Comparison

Compare NBN & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$130.50

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$24.31

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBN
SPTX
Founded
1872
N/A
Country
United States
United States
Employees
234
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
NBN
SPTX
Price
$130.50
$24.31
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$130.50
N/A
AVG Volume (30 Days)
99.6K
104.0K
Earning Date
04-27-2026
N/A
Dividend Yield
0.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.77
N/A
Revenue Next Year
$18.72
N/A
P/E Ratio
$11.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$80.75
$17.59
52 Week High
$142.31
$26.32

Technical Indicators

Market Signals
Indicator
NBN
SPTX
Relative Strength Index (RSI) 47.77 65.81
Support Level $127.84 $18.72
Resistance Level $137.75 N/A
Average True Range (ATR) 2.97 1.44
MACD -0.49 0.09
Stochastic Oscillator 23.82 70.22

Price Performance

Historical Comparison
NBN
SPTX

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: